Cargando…

Intolerance of sublingual buprenorphine-naloxone during induction in a patient with end-stage liver disease: A case report

INTRODUCTION: Sublingual buprenorphine is indicated for opioid dependence. It comes in 2 formulations: a mono buprenorphine product (BUP) and a combination product containing naloxone (BUP-NAL), which functions as an abuse deterrent. Sublingual naloxone does not reach clinically significant levels e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behan, Jennifer, Geier, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2016
Materias:	Addictive Disorder Treatments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007647/ https://www.ncbi.nlm.nih.gov/pubmed/29955460 http://dx.doi.org/10.9740/mhc.2016.05.131

Ejemplares similares

Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
por: Norton, Merrill, et al.
Publicado: (2016)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Benzodiazepine use, misuse, and abuse: A review
por: Schmitz, Allison
Publicado: (2016)

Evaluating nursing satisfaction and utilization of the Clinical Institute Withdrawal Assessment for Alcohol, revised version (CIWA-Ar)
por: Bacon, Opal, et al.
Publicado: (2016)

Paramedic-supplied ‘Take Home’ Naloxone: protocol for cluster randomised feasibility study
por: Moore, Chris, et al.
Publicado: (2014)

Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada
por: Allen, Sean T., et al.
Publicado: (2022)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial
por: Orkin, Aaron, et al.
Publicado: (2019)

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales
por: Marteau, Dave, et al.
Publicado: (2015)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Treating gambling disorder with as needed administration of intranasal naloxone: a pilot study to evaluate acceptability, feasibility and outcomes
por: Castrén, Sari, et al.
Publicado: (2019)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
por: Kaski, Shane, et al.
Publicado: (2021)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
por: Gunderson, Erik W., et al.
Publicado: (2016)

Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers
por: Fischer, Andreas, et al.
Publicado: (2015)

Applications of research evidence during processes to acquire approvals for syringe services program implementation in rural counties in Kentucky
por: Allen, Sean T., et al.
Publicado: (2022)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Opioid overdose decedent characteristics during COVID-19
por: Garcia, Gian-Gabriel P., et al.
Publicado: (2022)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Systematic critical review of previous economic evaluations of smoking cessation during pregnancy
por: Jones, Matthew, et al.
Publicado: (2015)

Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio
por: Young, April M, et al.
Publicado: (2022)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Contingency management for tobacco smoking during opioid addiction treatment: a randomised pilot study
por: Ainscough, Tom Stephen, et al.
Publicado: (2017)

Medical professionals' perspectives on prescribed and over-the-counter medicines containing codeine: a cross-sectional study
por: Foley, Michelle, et al.
Publicado: (2016)

Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam
por: Do, Huyen Phuc, et al.
Publicado: (2017)

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder
por: Clingan, Sarah E., et al.
Publicado: (2023)

Experience of LGBTQIA2S+ populations with gambling during the COVID-19 pandemic: protocol for a mixed-methods study
por: Brodeur, Magaly, et al.
Publicado: (2023)

Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
por: Coish, Rebecca, et al.
Publicado: (2023)

Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects
por: Cuzen, Natalie L, et al.
Publicado: (2015)

Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
por: Kennalley, Amy L, et al.
Publicado: (2023)

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
por: Scott, Gemma, et al.
Publicado: (2023)

Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine
por: Simpson, Kevin J, et al.
Publicado: (2019)

Understanding polysubstance use at the daily and event levels: protocol for a mixed-methods qualitative and ecological momentary assessment study in a community-based sample of people who use illicit drugs in Oakland, California, USA
por: Lorvick, Jennifer, et al.
Publicado: (2023)

Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol
por: Rosenkranz, Moritz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_40vuu1ndg79cgbj7nvilfi8pjs